Finding the Funds

Are the existing approaches to financing ATMP developers fit for purpose; what should analysts really be looking for in an Advanced Therapy?

FACILITATED BY

SARAH BRUCE-WHITE | Partnerships & Programme’s Lead | MedCity

PANELLISTS INCLUDE

JASON MELLAD | Chief Executive Officer | Start Codon
FABIO d’AGOSTINO | Venture Partner | Claris Ventures
ERIC HALIOUA | President & Chief Executive Officer | PDC*line Pharma
TIMOTHY NEWTON | Chief Executive Officer | Reflection Therapeutics